Correction: Resveratrol synergizes with cisplatin to suppress osteosarcoma U2-OS cells via up-regulating Cx43 and inducing ROS-dependent apoptosis

Hong-Bo Xing, Hao-Yu Li, Gui-Zhou Zheng, Qi-Hao Zhang, Lei Zhai, Xiang Wu, Shi-Xin Du, Xue-Dong Li · 2026

Read Correction: Resveratrol synergizes with cisplatin to suppress osteosarcoma U2-OS cells via up-regulating Cx43 and inducing ROS-dependent apoptosis by Hong-Bo Xing, Hao-Yu Li, Gui-Zhou Zheng, Qi-Hao Zhang, Lei Zhai, Xiang Wu, Shi-Xin Du, Xue-Dong Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13534365.txt.

Description

A 2026 correction notice replaces one figure panel in a study of bone cancer cells. The study, by Xing and co-authors, tested whether resveratrol, a compound found in grapes, helps the chemo drug cisplatin against osteosarcoma cells. A protein band panel in Figure 3 was published in error, and the notice shows the wrong and right versions side by side. The figure covers tests of how treated cells move and invade, plus levels of proteins tied to spread. The original article has been updated.

Catalog record

CREATORHong-Bo Xing, Hao-Yu Li, Gui-Zhou Zheng, Qi-Hao Zhang, Lei Zhai, Xiang Wu, Shi-Xin Du, Xue-Dong Li
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13534365

Browse the full library · About the Tower of Babel